We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AYLA
10901
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$148K ﹤0.01%
+135,502
New +$310K
ADMA icon
10902
PUT
ADMA Biologics
ADMA
$2.12B
$147K ﹤0.01%
74,200
+8,800
+13% +$17.3K
DSP icon
10903
Viant Technology
DSP
$275M
$147K ﹤0.01%
28,904
+1,552
+6% +$9.3K
INMB icon
10904
INmune Bio
INMB
$60.2M
$147K ﹤0.01%
16,663
-9,803
-37% -$73K
OPAD icon
10905
PUT
Offerpad Solutions
OPAD
$21.5M
$147K ﹤0.01%
451
+146
+48% +$98K
AAC.WS
10906
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$147K ﹤0.01%
634,972
+41,842
+7% +$13K
BTF icon
10907
CALL
CoinShares Bitcoin and Ether ETF
BTF
$13.6M
$146K ﹤0.01%
4,040
-1,800
-31% -$113K
CENN icon
10908
CALL
Cenntro
CENN
$8.63M
$146K ﹤0.01%
161
+46
+40% +$48.7K
PWSC
10909
CALL
DELISTED
PowerSchool Holdings, Inc.
PWSC
$146K ﹤0.01%
+12,100
New +$166K
BGXX
10910
DELISTED
Bright Green Corporation Common Stock
BGXX
$146K ﹤0.01%
+65,929
New +$451K
DCRDW
10911
DELISTED
Decarbonization Plus Acquisition Corporation IV Warrant
DCRDW
$146K ﹤0.01%
727,699
-19,902
-3% -$8.71K
AKYA
10912
CALL
DELISTED
Akoya BioSciences
AKYA
$145K ﹤0.01%
+11,300
New +$117K
EVLV icon
10913
Evolv Technologies
EVLV
$1.05B
$145K ﹤0.01%
54,463
+41,488
+320% +$110K
IMUX icon
10914
PUT
Immunic
IMUX
$219M
$145K ﹤0.01%
4,170
-1,150
-22% -$73.7K
OCSL icon
10915
CALL
Oaktree Specialty Lending
OCSL
$1.14B
$145K ﹤0.01%
7,400
-8,700
-54% -$183K
EXAI
10916
CALL
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$145K ﹤0.01%
+13,300
New +$159K
EQRX
10917
PUT
DELISTED
EQRx, Inc. Common Stock
EQRX
$145K ﹤0.01%
30,900
+11,000
+55% +$49.6K
SHQAW
10918
DELISTED
Shelter Acquisition Corporation I Warrants
SHQAW
$145K ﹤0.01%
804,369
-17,000
-2% -$4.72K
NSR
10919
PUT
DELISTED
Nomad Royalty Company Ltd.
NSR
$145K ﹤0.01%
20,600
+8,000
+63% +$61.7K
AMBP icon
10920
PUT
Ardagh Metal Packaging
AMBP
$3.13B
$144K ﹤0.01%
23,600
+8,300
+54% +$56.1K
ETV
10921
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.76B
$144K ﹤0.01%
+10,658
New +$153K
MTW icon
10922
CALL
Manitowoc
MTW
$746M
$144K ﹤0.01%
+13,700
New +$172K
TBPH icon
10923
Theravance Biopharma
TBPH
$881M
$144K ﹤0.01%
15,908
-635
-4% -$5.85K
MGI
10924
PUT
DELISTED
MoneyGram International, Inc. New
MGI
$144K ﹤0.01%
14,400
-75,800
-84% -$763K
STON
10925
DELISTED
StoneMor Inc.
STON
$144K ﹤0.01%
+42,004
New +$119K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.